Cargando…
TERT promoter mutation and chromosome 6 loss define a high-risk subtype of ependymoma evolving from posterior fossa subependymoma
Subependymomas are benign tumors characteristically encountered in the posterior fossa of adults that show distinct epigenetic profiles assigned to the molecular group “subependymoma, posterior fossa” (PFSE) of the recently established DNA methylation-based classification of central nervous system t...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113189/ https://www.ncbi.nlm.nih.gov/pubmed/33755803 http://dx.doi.org/10.1007/s00401-021-02300-8 |
_version_ | 1783690806498951168 |
---|---|
author | Thomas, Christian Thierfelder, Felix Träger, Malte Soschinski, Patrick Müther, Michael Edelmann, Dominic Förster, Alexandra Geiler, Carola Kim, Hee-yeong Filipski, Katharina Harter, Patrick N. Schittenhelm, Jens Eckert, Franziska Ntoulias, Georgios May, Sven-Axel Stummer, Walter Onken, Julia Vajkoczy, Peter Schüller, Ulrich Heppner, Frank L. Capper, David Koch, Arend Kaul, David Paulus, Werner Hasselblatt, Martin Schweizer, Leonille |
author_facet | Thomas, Christian Thierfelder, Felix Träger, Malte Soschinski, Patrick Müther, Michael Edelmann, Dominic Förster, Alexandra Geiler, Carola Kim, Hee-yeong Filipski, Katharina Harter, Patrick N. Schittenhelm, Jens Eckert, Franziska Ntoulias, Georgios May, Sven-Axel Stummer, Walter Onken, Julia Vajkoczy, Peter Schüller, Ulrich Heppner, Frank L. Capper, David Koch, Arend Kaul, David Paulus, Werner Hasselblatt, Martin Schweizer, Leonille |
author_sort | Thomas, Christian |
collection | PubMed |
description | Subependymomas are benign tumors characteristically encountered in the posterior fossa of adults that show distinct epigenetic profiles assigned to the molecular group “subependymoma, posterior fossa” (PFSE) of the recently established DNA methylation-based classification of central nervous system tumors. In contrast, most posterior fossa ependymomas exhibit a more aggressive biological behavior and are allocated to the molecular subgroups PFA or PFB. A subset of ependymomas shows epigenetic similarities with subependymomas, but the precise biology of these tumors and their potential relationships remain unknown. We therefore set out to characterize epigenetic traits, mutational profiles, and clinical outcomes of 50 posterior fossa ependymal tumors of the PFSE group. On histo-morphology, these tumors comprised 12 ependymomas, 14 subependymomas and 24 tumors with mixed ependymoma–subependymoma morphology. Mixed ependymoma–subependymoma tumors varied in their extent of ependymoma differentiation (2–95%) but consistently exhibited global epigenetic profiles of the PFSE group. Selective methylome analysis of microdissected tumor components revealed CpG signatures in mixed tumors that coalesce with their pure counterparts. Loss of chr6 (20/50 cases), as well as TERT mutations (21/50 cases), were frequent events enriched in tumors with pure ependymoma morphology (p < 0.001) and confined to areas with ependymoma differentiation in mixed tumors. Clinically, pure ependymoma phenotype, chr6 loss, and TERT mutations were associated with shorter progression-free survival (each p < 0.001). In conclusion, our results suggest that subependymomas may acquire genetic and epigenetic changes throughout tumor evolution giving rise to subclones with ependymoma morphology (resulting in mixed tumors) that eventually overpopulate the subependymoma component (pure PFSE ependymomas). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00401-021-02300-8. |
format | Online Article Text |
id | pubmed-8113189 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-81131892021-05-13 TERT promoter mutation and chromosome 6 loss define a high-risk subtype of ependymoma evolving from posterior fossa subependymoma Thomas, Christian Thierfelder, Felix Träger, Malte Soschinski, Patrick Müther, Michael Edelmann, Dominic Förster, Alexandra Geiler, Carola Kim, Hee-yeong Filipski, Katharina Harter, Patrick N. Schittenhelm, Jens Eckert, Franziska Ntoulias, Georgios May, Sven-Axel Stummer, Walter Onken, Julia Vajkoczy, Peter Schüller, Ulrich Heppner, Frank L. Capper, David Koch, Arend Kaul, David Paulus, Werner Hasselblatt, Martin Schweizer, Leonille Acta Neuropathol Original Paper Subependymomas are benign tumors characteristically encountered in the posterior fossa of adults that show distinct epigenetic profiles assigned to the molecular group “subependymoma, posterior fossa” (PFSE) of the recently established DNA methylation-based classification of central nervous system tumors. In contrast, most posterior fossa ependymomas exhibit a more aggressive biological behavior and are allocated to the molecular subgroups PFA or PFB. A subset of ependymomas shows epigenetic similarities with subependymomas, but the precise biology of these tumors and their potential relationships remain unknown. We therefore set out to characterize epigenetic traits, mutational profiles, and clinical outcomes of 50 posterior fossa ependymal tumors of the PFSE group. On histo-morphology, these tumors comprised 12 ependymomas, 14 subependymomas and 24 tumors with mixed ependymoma–subependymoma morphology. Mixed ependymoma–subependymoma tumors varied in their extent of ependymoma differentiation (2–95%) but consistently exhibited global epigenetic profiles of the PFSE group. Selective methylome analysis of microdissected tumor components revealed CpG signatures in mixed tumors that coalesce with their pure counterparts. Loss of chr6 (20/50 cases), as well as TERT mutations (21/50 cases), were frequent events enriched in tumors with pure ependymoma morphology (p < 0.001) and confined to areas with ependymoma differentiation in mixed tumors. Clinically, pure ependymoma phenotype, chr6 loss, and TERT mutations were associated with shorter progression-free survival (each p < 0.001). In conclusion, our results suggest that subependymomas may acquire genetic and epigenetic changes throughout tumor evolution giving rise to subclones with ependymoma morphology (resulting in mixed tumors) that eventually overpopulate the subependymoma component (pure PFSE ependymomas). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00401-021-02300-8. Springer Berlin Heidelberg 2021-03-23 2021 /pmc/articles/PMC8113189/ /pubmed/33755803 http://dx.doi.org/10.1007/s00401-021-02300-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Paper Thomas, Christian Thierfelder, Felix Träger, Malte Soschinski, Patrick Müther, Michael Edelmann, Dominic Förster, Alexandra Geiler, Carola Kim, Hee-yeong Filipski, Katharina Harter, Patrick N. Schittenhelm, Jens Eckert, Franziska Ntoulias, Georgios May, Sven-Axel Stummer, Walter Onken, Julia Vajkoczy, Peter Schüller, Ulrich Heppner, Frank L. Capper, David Koch, Arend Kaul, David Paulus, Werner Hasselblatt, Martin Schweizer, Leonille TERT promoter mutation and chromosome 6 loss define a high-risk subtype of ependymoma evolving from posterior fossa subependymoma |
title | TERT promoter mutation and chromosome 6 loss define a high-risk subtype of ependymoma evolving from posterior fossa subependymoma |
title_full | TERT promoter mutation and chromosome 6 loss define a high-risk subtype of ependymoma evolving from posterior fossa subependymoma |
title_fullStr | TERT promoter mutation and chromosome 6 loss define a high-risk subtype of ependymoma evolving from posterior fossa subependymoma |
title_full_unstemmed | TERT promoter mutation and chromosome 6 loss define a high-risk subtype of ependymoma evolving from posterior fossa subependymoma |
title_short | TERT promoter mutation and chromosome 6 loss define a high-risk subtype of ependymoma evolving from posterior fossa subependymoma |
title_sort | tert promoter mutation and chromosome 6 loss define a high-risk subtype of ependymoma evolving from posterior fossa subependymoma |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113189/ https://www.ncbi.nlm.nih.gov/pubmed/33755803 http://dx.doi.org/10.1007/s00401-021-02300-8 |
work_keys_str_mv | AT thomaschristian tertpromotermutationandchromosome6lossdefineahighrisksubtypeofependymomaevolvingfromposteriorfossasubependymoma AT thierfelderfelix tertpromotermutationandchromosome6lossdefineahighrisksubtypeofependymomaevolvingfromposteriorfossasubependymoma AT tragermalte tertpromotermutationandchromosome6lossdefineahighrisksubtypeofependymomaevolvingfromposteriorfossasubependymoma AT soschinskipatrick tertpromotermutationandchromosome6lossdefineahighrisksubtypeofependymomaevolvingfromposteriorfossasubependymoma AT muthermichael tertpromotermutationandchromosome6lossdefineahighrisksubtypeofependymomaevolvingfromposteriorfossasubependymoma AT edelmanndominic tertpromotermutationandchromosome6lossdefineahighrisksubtypeofependymomaevolvingfromposteriorfossasubependymoma AT forsteralexandra tertpromotermutationandchromosome6lossdefineahighrisksubtypeofependymomaevolvingfromposteriorfossasubependymoma AT geilercarola tertpromotermutationandchromosome6lossdefineahighrisksubtypeofependymomaevolvingfromposteriorfossasubependymoma AT kimheeyeong tertpromotermutationandchromosome6lossdefineahighrisksubtypeofependymomaevolvingfromposteriorfossasubependymoma AT filipskikatharina tertpromotermutationandchromosome6lossdefineahighrisksubtypeofependymomaevolvingfromposteriorfossasubependymoma AT harterpatrickn tertpromotermutationandchromosome6lossdefineahighrisksubtypeofependymomaevolvingfromposteriorfossasubependymoma AT schittenhelmjens tertpromotermutationandchromosome6lossdefineahighrisksubtypeofependymomaevolvingfromposteriorfossasubependymoma AT eckertfranziska tertpromotermutationandchromosome6lossdefineahighrisksubtypeofependymomaevolvingfromposteriorfossasubependymoma AT ntouliasgeorgios tertpromotermutationandchromosome6lossdefineahighrisksubtypeofependymomaevolvingfromposteriorfossasubependymoma AT maysvenaxel tertpromotermutationandchromosome6lossdefineahighrisksubtypeofependymomaevolvingfromposteriorfossasubependymoma AT stummerwalter tertpromotermutationandchromosome6lossdefineahighrisksubtypeofependymomaevolvingfromposteriorfossasubependymoma AT onkenjulia tertpromotermutationandchromosome6lossdefineahighrisksubtypeofependymomaevolvingfromposteriorfossasubependymoma AT vajkoczypeter tertpromotermutationandchromosome6lossdefineahighrisksubtypeofependymomaevolvingfromposteriorfossasubependymoma AT schullerulrich tertpromotermutationandchromosome6lossdefineahighrisksubtypeofependymomaevolvingfromposteriorfossasubependymoma AT heppnerfrankl tertpromotermutationandchromosome6lossdefineahighrisksubtypeofependymomaevolvingfromposteriorfossasubependymoma AT capperdavid tertpromotermutationandchromosome6lossdefineahighrisksubtypeofependymomaevolvingfromposteriorfossasubependymoma AT kocharend tertpromotermutationandchromosome6lossdefineahighrisksubtypeofependymomaevolvingfromposteriorfossasubependymoma AT kauldavid tertpromotermutationandchromosome6lossdefineahighrisksubtypeofependymomaevolvingfromposteriorfossasubependymoma AT pauluswerner tertpromotermutationandchromosome6lossdefineahighrisksubtypeofependymomaevolvingfromposteriorfossasubependymoma AT hasselblattmartin tertpromotermutationandchromosome6lossdefineahighrisksubtypeofependymomaevolvingfromposteriorfossasubependymoma AT schweizerleonille tertpromotermutationandchromosome6lossdefineahighrisksubtypeofependymomaevolvingfromposteriorfossasubependymoma |